Permitted Use Products are supplied solely for in vitro laboratory research, scientific investigation, and educational study by qualified researchers, research institutions, and analytical laboratories
Compounding serves legitimate medical needs, particularly when: A patient needs a dose strength not commercially available A patient is allergic to an inactive ingredient in the commercial product A patient needs a different delivery method (e.g., liquid instead of pill) Commercial supply shortages create access issues Compounded drugs are not FDA-approved as finished products
Same inclusions as the injectable program but with the oral delivery method
Systemic inflammation, mediated by cytokines like IL-6 and TNF-, can affect vagal tone and enteric signaling in ways that mimic GLP-1 action, particularly delayed gastric emptying and nausea [6-8]
Will my GLP-1 lawsuit go to trial